Lysosomal storage disease - PDFSEARCH.IO - Document Search Engine

Lysosomal storage disease
Results: 211

#	Item
111	SYNAGEVA BIOPHARMA™ ANNOUNCES PRESENTATIONS AND A SATELLITE SYMPOSIUM AT THE NATIONAL LIPID ASSOCIATION MEETING LEXINGTON, Mass., May 31, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical c Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-05-31 11:41:10 Medicine Lysosomal Acid Lipase Deficiency Cholesteryl ester storage disease Wolman disease Lysosomal storage disease Mucopolysaccharidosis Lysosomal lipase Sanfilippo syndrome Atherosclerosis Health Rare diseases Lipid storage disorders
112	LATE ONSET LAL DEFICIENCY (CESD) LITERATURE REVIEW PUBLISHED IN THE JOURNAL OF HEPATOLOGY LEXINGTON, Mass., March 26, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a clinical stage biopharmaceutical company Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-03-26 07:29:22 Rare diseases Hepatology Cardiology Lipoproteins Cholesteryl ester storage disease Wolman disease Lysosomal Acid Lipase Deficiency Cirrhosis Lysosomal storage disease Medicine Health Lipid storage disorders
113	SYNAGEVA BIOPHARMA™ HIGHLIGHTS SEBELIPASE ALFA AND LAL DEFICIENCY DATA AT THE LYSOSOMAL DISEASE NETWORK (LDN) WORLD SYMPOSIUM™ LEXINGTON, Mass., February 13, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-02-13 14:27:52 Medicine Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Hunter syndrome Low-density lipoprotein Mucopolysaccharidosis Cirrhosis Health Rare diseases Lipid storage disorders
114	SYNAGEVA BIOPHARMA™ HIGHLIGHTS SBC-103 DATA AT THE LYSOSOMAL DISEASE NETWORK (LDN) WORLD SYMPOSIUM™ LEXINGTON, Mass., February 12, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical compan Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-02-12 15:27:02 Syndromes Sanfilippo syndrome Wolman disease Mucopolysaccharidosis Cholesteryl ester storage disease Lysosomal storage disease Hunter syndrome Blood–brain barrier Health Rare diseases Lipid storage disorders
115	SYNAGEVA BIOPHARMA™ REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS LEXINGTON, Mass., July 30, [removed]Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-08-04 12:07:09 Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Mucopolysaccharidosis Hunter syndrome Health Rare diseases Lipid storage disorders
116	SYNAGEVA BIOPHARMA™ ISSUED U.S. PATENT FOR TREATMENT OF LAL DEFICIENCY LEXINGTON, Mass., March 4, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-03-04 08:05:19 Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Mucopolysaccharidosis Sanfilippo syndrome Acid lipase disease Wolman Rare diseases Health Lipid storage disorders
117	SYNAGEVA BIOPHARMA™ REPORTS POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF SEBELIPASE ALFA IN CHILDREN AND ADULTS WITH LAL DEFICIENCY Phase 3 Study Meets Primary Endpoint and Six Secondary Endpoints Across Multiple Di Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-10-09 07:26:12 Medicine Cardiology Lipoproteins Lysosomal Acid Lipase Deficiency Clinical research Cholesteryl ester storage disease Wolman disease Niacin Clinical trial Health Rare diseases Lipid storage disorders
118	SYNAGEVA BIOPHARMA™ ANNOUNCES SATELLITE SYMPOSIUM AT THE NATIONAL LIPID ASSOCIATION MEETING LEXINGTON, Mass., May 2, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing the Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-05-02 07:29:47 Wolman disease Cholesteryl ester storage disease Sanfilippo syndrome Mucopolysaccharidosis Lysosomal storage disease Lysosomal Acid Lipase Deficiency Health Rare diseases Lipid storage disorders
119	LAL DEFICIENCY DISEASE REVIEW PUBLISHED IN ATHEROSCLEROSIS LEXINGTON, Mass., April 21, [removed]Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare dise Add to Reading List Source URL: www.synageva.com Language: English - Date: 2014-04-21 08:00:38 Medicine Lysosomal Acid Lipase Deficiency Wolman disease Cholesteryl ester storage disease Lysosomal storage disease Acid lipase disease Mucopolysaccharidosis Sanfilippo syndrome Lysosomal lipase Health Rare diseases Lipid storage disorders
120	SYNAGEVA’S SEBELIPASE ALFA RECEIVES BREAKTHROUGH THERAPY DESIGNATION FOR EARLY ONSET LAL DEFICIENCY FROM THE U.S. FOOD AND DRUG ADMINISTRATION LEXINGTON, Mass., May 20, [removed]Synageva BioPharma Corp. (Synageva) (NASD Add to Reading List Source URL: www.synageva.com Language: English - Date: 2013-05-20 07:13:10 Wolman disease Lysosomal Acid Lipase Deficiency Cholesteryl ester storage disease Lysosomal storage disease Mucopolysaccharidosis Sanfilippo syndrome Wolman Acid lipase disease Lysosomal lipase Health Rare diseases Lipid storage disorders

UPDATE